Advancing the impact of molecular testing and diagnostics
We’re on a mission to use our open, accessible, and actionable molecular detection platform to detect pathogens before they spread.
The Alveo platform brings molecular detection out of the lab and into the field.
In an increasingly interconnected world, early detection of pathogens is crucial for both people and industries
Three out of four new or emerging infectious diseases in people come from animals.
Rapid detection leads to earlier insight into pathogen spread can support efforts to secure global health and prevent future pandemics.
Name Surname
Position, Company name
Get to know the Alveo Platform
Harnessing the power of our molecular detection platform, Alveo enables pathogen detection for a growing number of fields precisely when — and where — it matters most.
Alveo operations are certified to the ISO13485 standard and the be.well™ platform has achieved a CE mark for commercial use in Europe.
In Vitro Devices (IVD) certified for the commercialization in European Union
ISO certification for the design, development, and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease
Winner: XPRIZE Grand Prize for Rapid Covid testing
